ALDOA and non-small cell lung carcinoma: In this study, we analyzed the effect of ALDOA knockdown on the proliferation and cell cycle progression of NSCLC and further explored the underling mechanisms and potential of ALDOA as a biomarker or drug target for NSCLC.